Advertisement
Advertisement
Sino Biopharmaceutical
TOPIC
 / company

Sino Biopharmaceutical

Sino Biopharmaceutical
Sino Biopharmaceutical
Sino Biopharmaceutical develops, manufactures and markets pharmaceuticals, biopharmaceuticals and Chinese medicines. It offers products to treat conditions ranging from hepatitis to respiratory and digestive diseases. It is a subsidiary of Thailand's Charoen Pokphand Group.
Chairman / President
Theresa Tse
CEO / Managing Director
Tse, Eric S Y
CFO / Finance Director
Li Chunling
Industry
Pharmaceuticals
Website
sinobiopharm.com
Headquarters address
Unit 09, 41/F, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong
Stock Code
SEHK:1177
Year founded
2000
LATEST China Science NEWS

From years to a week: China’s superfast software for hypersonic weapon design

videocam
12
Long-range CJ-1000 cruise missiles are displayed during a military parade in Beijing on September 3, 2025. Photo: AFP

NIH-awarded life scientist Shu Xiaokun abruptly shifts research from US to China

videocam
4
Shu Xiaokun (right) was the Herfindahl Endowed Chair and a tenured professor at the University of California, San Francisco. According to the Fudan University, he has returned to Shanghai to join the faculty as a distinguished professor. Photo: Handout

Can China commercial satellite’s ‘octopus tentacle’ pass low-orbit refuel test?

videocam
Hukeda-2 is China’s first commercial test satellite equipped with a flexible robotic arm, according to the state-owned Science and Technology Daily. Photo: Handout

Liu Guozhi, once top PLA scientist, wiped off Chinese Academy of Sciences site

videocam
7
Liu Guozhi, 65, once headed the science and technology commission of the Central Military Commission – China’s top military decision-making and command body. Photo: Handout

Leading Chinese remote-sensing scientist Zhang Jinshui dies at 47

videocam
Zhang Jinshui was a professor and doctoral supervisor in the Faculty of Geographical Science, Beijing Normal University. Photo: Handout
MORE China Science NEWS
Overseas capital tends to cherry-pick a few big-cap pharmaceutical companies rather than buy the biotech sector broadly, according to an analyst. Photo: Handout
Banking & finance

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

Made in China 2025

China biotech outlicensing tops US$52 billion in first 2 months

Banking & finance

Global funds, from BlackRock to Temasek, back China’s largest biotech firms

Hong Kong stock market

Hong Kong stocks edge higher on last full trading day of year

Hang Seng Index edges higher as Chinese yuan surpasses 7 against US dollar for first time since May 2023.

People walk past Exchange Square in Central, home of Hong Kong’s bourse operator, on March 28, 2025. Photo: Matthew Miller
Made in China 2025

China’s pharmaceutical industry transforms into a global innovation powerhouse

The China Pharmaceutical Innovation and Invention Index, a new gauge, highlights top drug makers on the mainland for the first time.

Biomedicine: Industry Trends

China’s drug developers stretch to become a global force

Although a start-up’s recent triumph is seen as a ‘DeepSeek moment’, domestic players still trail world-beating pharma firms, experts say.

10
Advertisement
Advertisement
Advertisement
Hong Kong stock market

Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers

The Trump administration has been discussing severe restrictions on medicines from China, according to The New York Times.

Hong Kong stocks fell on Thursday. Photo: EPA
Hong Kong stock market

Hong Kong stocks rise on China policy hopes after soft economic data

China’s industrial output and fixed-asset investment fell short in May, and the downturn in the property market deepened.

Hong Kong stock market

Hong Kong stocks fall on rising geopolitical tensions

Israel launches air strikes targeting both nuclear and military sites and officials leading Iran’s nuclear programme.

Hong Kong stock market

Hong Kong stocks fall on US trade threats and interest rate uncertainty

US President Donald Trump says he will unveil unilateral tariff rates within two weeks.

People walk through Exchange Square in Central. Photo: EPA-EFE
Science

US approves China-invented painkiller that could reduce fentanyl overdoses

Qamzova is a non-steroidal anti-inflammatory that provides 24-hour pain relief in a single shot, reducing post-surgery opioid reliance.

videocam
23
A single injection of the meloxicam-based medication Qamzova, developed by Chinese biotech firm Delova, provides 24 hours of post-surgery pain relief. Photo: Sina
Hong Kong stock market

China’s first rate cut in 7 months drives Hong Kong stocks to 2-month high

Lower borrowing costs will be a major driver for stocks, Guotai Haitong Securities analysts Fang Yi says.

Science

Drug trial offers hope for patients with hard-to-treat lung cancer in China, US

New medication appears to be safer and more effective than standard therapy, according to trial led by Chinese and US scientists.

videocam
7
Coronavirus pandemic

Sino Biopharm invests US$515 million in Sinovac’s Covid-19 vaccine unit

Beijing-based generic drug maker buys 15 per cent stake in Sinovac Life Sciences, a unit of Nasdaq-listed pharmaceutical firm Sinovac Biotech.

videocam
Sinovac Biotech’s CoronaVac Covid-19 vaccine candidate has been undergoing phase three trials in many countries, including Brazil and Turkey. Photo: AFP
Stocks

Stocks Blog: China stocks gain ahead of global financial leaders' teleconference call on coronavirus

Reuters reports draft statement of G7 leaders does not include specific, coordinated steps. That led to a pullback in Asia markets. In Hong Kong, Tencent, Ping An Good Doctor, China Tobacco International gained. In China, Kweichow Moutai advanced. 

US benchmarks surged overnight, as the world's leading finance ministers get ready to hold an emergency teleconference call Tuesday night Hong Kong time to figure out their response to the coronavirus.
Hang Seng Index

Sino Biopharmaceutical added to Hong Kong index amid Beijing biotech push

An index that tracks shares of mainland Chinese companies on the Hong Kong stock exchange will admit a pharmaceutical stock and a utility. The companies replace a railway company and a building materials producer, partly reflecting the changing profile of China’s economy.

Wealth management

Eric Tse, Rihanna’s selfie mate, is instant tycoon on US$3.8 billion gift

The share transfer is the latest in the tsunami of Asian wealth that’s being passed down to the next generation. In 2018, four Chinese tycoons tipped more than US$17 billion into family trusts, while many of Hong Kong’s biggest developers are going through succession planning.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement